We are delighted to be attending DeviceTalks Boston from 27–28 May 2026. Kristy Beede, Research Director, and Nicole Levin, Associate Director, will be representing Purdie Pascoe at the event.

With 2026 marking the Regulatory Affairs Professionals Society’s 50th anniversary, the atmosphere felt especially energised. Between packed auditoriums, poster sessions, and many conversations, one thing became increasingly clear: post-market evidence generation is entering a far more mature and strategically important phase.

We are thrilled to announce that Marcus Torr, Head of Post Market Surveys at Purdie Pascoe, has been selected for the MedTech Leading Voice (MLV) list for a second year in a row. Marcus regularly shares his expertise at industry events and on LinkedIn. We are incredibly proud to see him featured in the prestigious MLV100 list. Don't miss his future insights by following him on LinkedIn.

We are delighted to be attending, sponsoring and presenting at the RAPS Euro Convergence from 5-8 April in Lisbon. Purdie Pascoe’s Post Market Survey experts Marcus Torr (Head of Post Market Surveys) Ellie Baker (Commercial Director) Alice Robertson (Research Manager) and Ruby Pogson Jones (Senior Research Executive ) are exhibiting on booth 31.

We are delighted to be attending the ACC Annual Conference from March 28–30 in New Orleans, Louisiana. Senior Research Executives Molly Hines and Supreet Kaur will be representing Purdie Pascoe at the event.

We are delighted to be attending the SAGES Annual Conference from March 25–28 in Tampa, Florida. Kristin Lovallo, US Research Director, will be representing Purdie Pascoe at the event.

The 2026 MedTech Clinical Network Conference, hosted by TT Life Sciences in Brussels, brought together clinical leaders from across Europe at a pivotal time for the MedTech sector. Rather than simply revisiting regulatory updates, this year’s discussions focused on a broader challenge: how organisations can navigate uncertainty, strengthen clinical strategy, and generate evidence that delivers both regulatory assurance and commercial value.

Find out how we used a staged qualitative approach to help our client understand the landscape of digital solutions in GI endotherapy with a focus on AI, data management (clinical and non-clinical), workflow, and supply management.

As part of compliance with the EU Medical Device Regulation (MDR), the manufacturer of a Class III guidewire needed to generate robust Post Market Clinical Follow-Up (PMCF) data to confirm ongoing safety and performance. The study was designed to evaluate two key endpoints: procedural success, and freedom from adverse events.

Attending this year’s RAPS Congress we were reminded of why we do what we do; at the heart of every conversation from regulatory reform to AI innovation there was one shared purpose: improving patients’ lives.

Are you attending the RAPS European Lifecycle Management Conference from 28-29 October? Purdie Pascoe’s Head of Post Market Surveys, Marcus Torr will be attending and presenting.

We are delighted to be attending MedDev Day from 13-14 October 2025 in Budapest. Purdie Pascoe’s Head of Post Market Surveys, Marcus Torr will be attending and presenting at the conference.

Our client, a market-leading provider of vascular surgery products for aortic and peripheral vascular disease, wanted to understand how they could better service interventional cardiologists (ICs) and their patients by understanding ICs’ preferences, perceptions, and influences and priorities.

We are delighted to be the exhibiting at the RAPS Convergence, 7-9 October 2025 in Pittsburgh, US. Purdie Pascoe’s Post Market Survey experts Ellie Baker, Commercial Director and Chris Webb Research Manager | RCC- MDR are exhibiting on Booth 817.

Find out how we provided our client with a clear and effective path forward to help launch their pre-filled syringes for subcutaneous immunoglobulin therapy, and how best to position themselves for widespread adoption.

Harry Thomas is our dedicated Data Quality Assurance Officer at Purdie Pascoe. In this interview, Harry shares insights about his role and key processes from handling discrepancies or anomalies in collected data to how to adapt when working with new or evolving data collection technologies.

Our client’s device is used for a specific indication, however users identified a potential benefit of the device’s design to perform for another indication. This study differs from typical PMCF efforts, with an aim to update the device’s labelling (IFUs) with safety and feasibility data for the expanded use. Find out how we heled out client in collecting retrospective real-world data to support the indication expansion.

Ellie Baker recently joined Purdie Pascoe as PMCF Commercial Director. In this interview, Ellie shares why medical device manufacturers consider PMCF surveys, how she helps guide clients through the complexities of the MedTech landscape and how her first few weeks have been at the business.

The Purdie Pascoe Post Market Clinical Follow-up (PMCF) team was out in full force at this this year’s Regulatory Affairs Professionals Society (RAPS) convergence in Brussels. Marcus Torr, PMCF/MDR Lead, attended with newly appointed PMCF Commercial Director, Ellie Baker and PMCF Managers, Chris Webb and Tonika Chester.

As Senior PMCF Medical Writer at Purdie Pascoe, Priyal Sharma offers her perspective about the benefits of having an in-house medical writer at an insights agency, how she ensures accuracy and clarity when communicating complex medical information and how she collaborates with the wider PMCF team.